Cholesterol Screening To Aid In Glaucoma Detection

Cholesterol Screening To Aid In Glaucoma Detection Overview Although intraocular pressure is the primary risk factor for glaucoma, additional risk factors should also be considered. This systematic review and meta-analysis summarize the evidence of the association between cholesterol parameters (total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels) and glaucoma and

Ovarian adenocarcinoma with glaucoma: A case report

Ovarian adenocarcinoma with glaucoma: A case report Introduction Metastatic tumor accounts for the most common ocular malignancy in adults. In rare cases, ocular metastasis can represent the initial manifestation of an undiagnosed primary cancer such as breast and lung cancers. Patients usually present with visual field defects, ocular pain, floaters, photophobia, or

Optic 3D Modeling in Ophthalmic Treatment

Optic 3D Modeling in Ophthalmic Treatment Visual impairment is a global health concern. Visually impaired patients are at high risk for accidents, depression, and social withdrawal. Eye disorders like age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP) cause irreparable vision loss and affect the quality of life of

iStent Combination Therapy for Glaucoma and Cataracts

iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value. 

Combination IOP Reduction Therapy in Open-Angle Glaucoma

Combination IOP Reduction Therapy in Open-Angle Glaucoma GLAUCOMA BACKGROUND Globally, glaucoma is a leading cause of permanent blindness. As of 2020, about 80 million people worldwide, and 3 million Americans, are affected by glaucoma. The most common form of glaucoma is open-angle glaucoma. Unfortunately, the primary risk factor for open-angle glaucoma is

The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure

The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure Around 75 million people suffer from glaucoma, making it the world’s leading eye disorder that causes irreversible blindness. Vision loss in glaucoma patients is often accompanied by the dysfunction of the retinal ganglion cell axons. This is believed to

Cholesterol Screening To Aid In Glaucoma Detection